| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | The (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia. (Chemical Entities of Biological Interest Ontology, CHEBI_3721) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=CISATRACURIUM BESYLATE |
| Similar Terms | |
| Downloads & Tools |
7 interacting proteins for the CISATRACURIUM BESYLATE drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) | 0.763442 |
| CHRNG | cholinergic receptor, nicotinic, gamma (muscle) | 0.472607 |
| CHRND | cholinergic receptor, nicotinic, delta (muscle) | 0.4411 |
| CHRNE | cholinergic receptor, nicotinic, epsilon (muscle) | 0.330825 |
| CHRNB1 | cholinergic receptor, nicotinic, beta 1 (muscle) | 0.315071 |
| CHRNA1 | cholinergic receptor, nicotinic, alpha 1 (muscle) | 0.213435 |
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.00746783 |
